|
⚲
|
| Artielle Immunotherapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001298528 |
| Sale | 2009-09-17 ($0.8 M Offered, $0.7 M Sold) |
| Fund | |
| Phone | 5036261144 |
| Address | 9020 SW Washington Square Rd Tigard, 97223 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter McWilliams | |
| Gilbert Miller | |
| Paul Quadros | |
| Allan Wolfe | |
| Adolph Ferro | |
| Shahab Fatheazam |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
CP Princeton Investors, LLC
✚
|
0.0 | |
|
Chivaphongse Suthee
✚
|
0.0 | |
|
Crawley Brandon
✚
|
0.0 | |
|
Christ Eric J
✚
|
0.0 | |
|
Crenshaw Carol
✚
|
0.0 | |
|
Circe Biosciences Inc.
✚
|
0.0 | |
|
Crestline Equity Partners Series II LP
✚
|
0.0 | |
|
Crexendo, Inc.
✚
|
0.0 | |
|
Criterion El Luchador Henderson, LLC
✚
|
0.0 | |
|
Chilton Anton
✚
|
0.0 |